Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam.
Article in Antimicrobial Agents and Chemotherapy (September 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Antimicrobial Agents and Chemotherapy (September 2024)
Article in Frontiers in Microbiology (July 2024)
Article in Frontiers in Microbiology (May 2024)